Institutional Relative Strength Dashboard for Nifty 500 stocks (1-Month Return Spreads & 50-Day Mansfield Baseline).
| Stock & Price | Industry Sector | Market Benchmark RS (1M) | Segment & Sector RS (1M) | Mansfield RS (50D) ▼ | RS Rating |
|---|---|---|---|---|---|
|
IGIL
⚡ DA
International Gemological Institute Ltd.
₹438.90
|
🏷️ Services
Sector RS 63 (#8)
|
vs Nifty 50 (1M):
+27.53%
vs Nifty 500 (1M):
+30.75%
|
vs Mid/Small (1M):
+32.87%
vs Consumption (1M):
+28.51%
|
+17.58 | 99 |
|
SAREGAMA
⚡ DA
Saregama India Ltd
₹653.45
|
🏷️ Media Entertainment & Publication
Sector RS 42 (#12)
|
vs Nifty 50 (1M):
+19.73%
vs Nifty 500 (1M):
+22.95%
|
vs Mid/Small (1M):
+25.07%
vs Media (1M):
+23.30%
|
+16.43 | 99 |
|
SAILIFE
⚡ DA
🚀 CROSS (Day 5)
Sai Life Sciences Ltd.
₹1,928.80
|
🏷️ Healthcare
Sector RS 68 (#7)
|
vs Nifty 50 (1M):
+21.24%
vs Nifty 500 (1M):
+24.46%
|
vs Mid/Small (1M):
+26.58%
vs Healthcare (1M):
+21.88%
|
+14.52 | 99 |
|
KALYANKJIL
⚡ DA
🚀 CROSS (Day 4)
Kalyan Jewellers India Ltd.
₹697.00
|
🏷️ Consumer Durables
Sector RS 53 (#10)
|
vs Nifty 50 (1M):
+11.41%
vs Nifty 500 (1M):
+14.62%
|
vs Mid/Small (1M):
+16.74%
vs Consumption (1M):
+12.39%
|
+13.65 | 98 |
|
ATHERENERG
⚡ DA
Ather Energy Ltd.
₹1,945.00
|
🏷️ Automobile and Auto Components
Sector RS 89 (#3)
|
vs Nifty 50 (1M):
+19.45%
vs Nifty 500 (1M):
+22.67%
|
vs Mid/Small (1M):
+24.79%
vs Auto (1M):
+19.09%
|
+13.60 | 98 |
|
EMCURE
⚡ DA
Emcure Pharmaceuticals Ltd.
₹2,361.70
|
🏷️ Healthcare
Sector RS 68 (#7)
|
vs Nifty 50 (1M):
+15.73%
vs Nifty 500 (1M):
+18.95%
|
vs Mid/Small (1M):
+21.07%
vs Healthcare (1M):
+16.37%
|
+12.66 | 98 |
|
PVRINOX
⚡ DA
PVR INOX Ltd.
₹1,641.20
|
🏷️ Media Entertainment & Publication
Sector RS 42 (#12)
|
vs Nifty 50 (1M):
+6.19%
vs Nifty 500 (1M):
+9.41%
|
vs Mid/Small (1M):
+11.53%
vs Media (1M):
+9.76%
|
+12.06 | 98 |
|
PNB
⚡ DA
🚀 CROSS (Day 4)
Punjab National Bank
₹142.81
|
🏷️ Financial Services
Sector RS 94 (#2)
|
vs Nifty 50 (1M):
+11.87%
vs Nifty 500 (1M):
+15.09%
|
vs Mid/Small (1M):
+17.21%
vs FinServ (1M):
+10.88%
|
+11.01 | 98 |
|
DIVISLAB
⚡ DA
Divi's Laboratories Ltd.
₹11,442.00
|
🏷️ Healthcare
Sector RS 68 (#7)
|
vs Nifty 50 (1M):
+12.57%
vs Nifty 500 (1M):
+15.79%
|
vs Mid/Small (1M):
+17.91%
vs Healthcare (1M):
+13.21%
|
+10.81 | 97 |
|
ACUTAAS
⚡ DA
Acutaas Chemicals Ltd.
₹4,039.10
|
🏷️ Healthcare
Sector RS 68 (#7)
|
vs Nifty 50 (1M):
+16.49%
vs Nifty 500 (1M):
+19.70%
|
vs Mid/Small (1M):
+21.83%
vs Healthcare (1M):
+17.13%
|
+10.33 | 97 |
Please log in or create a free account to access Relative Strength Scanner and view live stock signals.
Relative Strength (RS) analysis is one of the most powerful institutional techniques used by market legendary traders like Stan Weinstein and William O'Neil to identify market leaders before major explosive price runs.
Measures the net performance difference between a stock's 1-month percentage return and a benchmark index (RS Spread % = Stock Return % − Benchmark Index Return %). Positive spreads indicate active momentum outperformance.
Normalizes relative strength around a zero baseline. When Mansfield RS is positive and crosses above zero, it signals a Stan Weinstein Stage 2 momentum breakout where a stock shifts from lagging to outperforming.
Percentile ranks each stock's weighted return against the entire Nifty 500 stock universe. A score of 95 means the stock is outperforming 95% of all stocks in the market.
Tags stocks that are outperforming BOTH the broad market (Nifty 50) and their specific Sectoral Index simultaneously, or making fresh 1–5 Day Mansfield RS 0 Crossovers into Stage 2 breakouts.
Match counts from every screener and IPO updates, every trading day.